SMC2-DT: A Protein Targeted for Cancer and Other Diseases (G101928550)

Target Name: SMC2-DT

NCBI ID: G101928550

SMC2-DT

Other Name(s): SMC2-AS1 | SMC2 divergent transcript

SMC2-DT: A Protein Targeted for Cancer and Other Diseases

SMC2-DT, also known as SMC2-AS1, is a protein that is expressed in various tissues of the body, including the nervous system, endocrine system, and immune system. It is a member of the small GTPase-activated protein (SMGIP) family and is involved in a wide range of cellular processes, including intracellular signaling, cell survival, and cell-cell communication.

SMC2-DT has been identified as a potential drug target due to its involvement in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions as a protein have been confirmed through various in vitro and in vivo studies, and its potential as a drug target is under investigation in clinical trials.

One of the key functions of SMC2-DT is its role in intracellular signaling. SMC2-DT is involved in the regulation of several intracellular signaling pathways, including the T-cell signaling pathway, the sonic hedgehog pathway, and the Wnt signaling pathway. These pathways are involved in a wide range of cellular processes, including cell growth, differentiation, and survival.

SMC2-DT has also been shown to play a role in cell-cell communication. It is involved in the formation of tight junctions, which are specialized barriers that regulate the movement of ions and molecules across the membrane of a cell. These barriers are essential for maintaining the integrity of the cell and for ensuring the proper exchange of nutrients and waste products.

SMC2-DT is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. This regulation is important for maintaining the integrity of tissues and for ensuring the proper functioning of various organs.

In addition to its role in intracellular signaling and cell-cell communication, SMC2-DT has also been shown to play a role in the regulation of cellular processes that are important for overall cellular health. For example, it is involved in the regulation of cell cycle progression, which is the process by which cells grow and divide, and it is also involved in the regulation of cellular signaling pathways that are important for cell survival.

SMC2-DT is a protein that has been identified as a potential drug target due to its involvement in various diseases. Its functions as a protein have been confirmed through various in vitro and in vivo studies, and its potential as a drug target is under investigation in clinical trials. Further research is needed to fully understand the role of SMC2-DT in cellular processes and to determine its potential as a drug target.

Protein Name: SMC2 Divergent Transcript

The "SMC2-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMC2-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets